Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Global plasma protein profiling reveals DCM characteristic protein signatures.

Feig MA, Pop C, Bhardwaj G, Sappa PK, Dörr M, Ameling S, Weitmann K, Nauck M, Lehnert K, Beug D, Kühl U, Schultheiss HP, Völker U, Felix SB, Hammer E.

J Proteomics. 2019 Oct 30;209:103508. doi: 10.1016/j.jprot.2019.103508. Epub 2019 Aug 30.

PMID:
31476444
2.

Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence.

Tschöpe C, Elsanhoury A, Schlieker S, Van Linthout S, Kühl U.

Eur J Heart Fail. 2019 Nov;21(11):1468-1469. doi: 10.1002/ejhf.1560. Epub 2019 Sep 2. No abstract available.

PMID:
31476088
3.

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series.

Tschöpe C, Van Linthout S, Spillmann F, Posch MG, Reinke P, Volk HD, Elsanhoury A, Kühl U.

Eur Heart J Case Rep. 2019 Sep 1;3(3). pii: ytz131. doi: 10.1093/ehjcr/ytz131.

4.

Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.

Zobel T, Bock CT, Kühl U, Rohde M, Lassner D, Schultheiss HP, Schmidt-Lucke C.

Viruses. 2019 Mar 6;11(3). pii: E227. doi: 10.3390/v11030227.

5.

CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5.

Lassner D, Siegismund CS, Kühl U, Rohde M, Stroux A, Escher F, Schultheiss HP.

J Transl Med. 2018 Sep 4;16(1):249. doi: 10.1186/s12967-018-1610-8.

6.

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.

Haghikia A, Schwab J, Vogel-Claussen J, Berliner D, Pfeffer T, König T, Zwadlo C, Moulig VA, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kühl U, Podewski E, Kindermann I, Böhm M, Sliwa K, Hilfiker-Kleiner D, Bauersachs J.

Clin Res Cardiol. 2019 Mar;108(3):290-297. doi: 10.1007/s00392-018-1355-7. Epub 2018 Aug 18.

7.

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity.

Van Linthout S, Elsanhoury A, Klein O, Sosnowski M, Miteva K, Lassner D, Abou-El-Enein M, Pieske B, Kühl U, Tschöpe C.

ESC Heart Fail. 2018 Oct;5(5):818-829. doi: 10.1002/ehf2.12341. Epub 2018 Aug 11.

8.

The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports.

Tschöpe C, Alogna A, Spillmann F, Faragli A, Schmidt G, Blaschke F, Kühl U, Hertel E, Willner M, Morris D, Post H, Noutsias M, Pieske B, Krackhardt F.

BMC Cardiovasc Disord. 2018 Jul 31;18(1):155. doi: 10.1186/s12872-018-0883-4.

9.

Return to work in heart failure patients with suspected viral myocarditis.

Reibis R, Kühl U, Salzwedel A, Rasawieh M, Eichler S, Wegscheider K, Völler H.

SAGE Open Med. 2017 Dec 12;5:2050312117744978. doi: 10.1177/2050312117744978. eCollection 2017.

10.

Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.

Müller I, Vogl T, Pappritz K, Miteva K, Savvatis K, Rohde D, Most P, Lassner D, Pieske B, Kühl U, Van Linthout S, Tschöpe C.

Circ Heart Fail. 2017 Nov;10(11). pii: e004125. doi: 10.1161/CIRCHEARTFAILURE.117.004125.

PMID:
29158436
11.

Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.

Siegismund CS, Escher F, Lassner D, Kühl U, Gross U, Fruhwald F, Wenzel P, Münzel T, Frey N, Linke RP, Schultheiss HP.

Eur J Heart Fail. 2018 Apr;20(4):751-757. doi: 10.1002/ejhf.1039. Epub 2017 Oct 25.

12.

Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy.

Schmidt-Lucke C, Zobel T, Escher F, Tschöpe C, Lassner D, Kühl U, Gubbe K, Volk HD, Schultheiss HP.

J Infect Dis. 2018 Jan 17;217(3):456-465. doi: 10.1093/infdis/jix309.

PMID:
28961998
13.

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.

Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J.

Eur Heart J. 2017 Sep 14;38(35):2671-2679. doi: 10.1093/eurheartj/ehx355.

14.

NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.

Tschöpe C, Müller I, Xia Y, Savvatis K, Pappritz K, Pinkert S, Lassner D, Heimesaat MM, Spillmann F, Miteva K, Bereswill S, Schultheiss HP, Fechner H, Pieske B, Kühl U, Van Linthout S.

Circ Heart Fail. 2017 Sep;10(9). pii: e003870. doi: 10.1161/CIRCHEARTFAILURE.117.003870.

PMID:
28912259
15.

High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy.

Escher F, Kühl U, Lassner D, Stroux A, Gross U, Westermann D, Pieske B, Poller W, Schultheiss HP.

J Am Heart Assoc. 2017 Aug 18;6(8). pii: e005352. doi: 10.1161/JAHA.116.005352.

16.

Shocks after implantable cardioverter-defibrillator implantation in idiopathic cardiomyopathy patients: a myocardial biopsy study.

Safak E, D Ancona G, Schultheiss HP, Kühl U, Kische S, Kaplan H, Ince H, Ortak J.

Heart Vessels. 2018 Feb;33(2):205-211. doi: 10.1007/s00380-017-1041-0. Epub 2017 Aug 14.

PMID:
28808788
17.

Multimodality imaging approach in the diagnosis of chronic myocarditis with preserved left ventricular ejection fraction (MCpEF): The role of 2D speckle-tracking echocardiography.

Kasner M, Aleksandrov A, Escher F, Al-Saadi N, Makowski M, Spillmann F, Genger M, Schultheiss HP, Kühl U, Pieske B, Morris DA, Noutsias M, Tschöpe C.

Int J Cardiol. 2017 Sep 15;243:374-378. doi: 10.1016/j.ijcard.2017.05.038. Epub 2017 May 16.

PMID:
28536004
18.

Reversible transition from a hypertrophic to a dilated cardiomyopathy.

Spillmann F, Kühl U, Van Linthout S, Dominguez F, Escher F, Schultheiss HP, Pieske B, Tschöpe C.

ESC Heart Fail. 2016 Jun;3(2):138-142. Epub 2015 Dec 9.

19.

Mitochondrial haplogroups and expression studies of commonly used human cell lines.

Siegismund CS, Schäfer I, Seibel P, Kühl U, Schultheiss HP, Lassner D.

Mitochondrion. 2016 Sep;30:236-47. doi: 10.1016/j.mito.2016.08.012. Epub 2016 Aug 22.

PMID:
27562426
20.

Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy.

Siegismund CS, Rohde M, Kühl U, Escher F, Schultheiss HP, Lassner D.

Genomics Proteomics Bioinformatics. 2016 Aug;14(4):224-34. doi: 10.1016/j.gpb.2016.04.005. Epub 2016 Jul 28.

Supplemental Content

Loading ...
Support Center